Wall Street analysts and major financial institutions are converging on a select group of technology and healthcare stocks as prime holdings for the coming year, with a strong emphasis on artificial intelligence (AI) and cloud computing growth. According to a recent analysis attributed to ChatGPT, Microsoft, NVIDIA, and Alphabet lead the pack with the highest buy ratings from analysts.
Microsoft holds the strongest analyst support with 48 buy ratings, six holds, and one sell, praised for its Azure cloud growth and AI integration across Office and enterprise software. NVIDIA commands 44 buy ratings, dominating the AI infrastructure market with strong GPU demand and its CUDA software ecosystem. Alphabet receives 41 buy ratings, viewed as a less crowded AI play with profitable search advertising and improving Google Cloud margins. Healthcare picks like Johnson & Johnson and CRISPR Therapeutics offer defensive stability and high-risk biotech exposure, respectively.
Separately, Bank of America has named NVIDIA, Palantir, and Robinhood among its top "buy and hold" stocks for 2025. The bank reiterated NVIDIA as its top sector pick, citing over 40% EPS growth potential and its shift from PC graphics to powering AI infrastructure. Palantir was labeled a top AI software name, with total customer count up 45% year-over-year and shares rising 123% in 2025; Bank of America raised its price target to $255 per share. Robinhood was highlighted for beating earnings and expanding its client base, with shares skyrocketing 245% year-to-date.
Other mentions include Crane for consistency in aerospace and defense, Supernus Pharmaceuticals as an underappreciated growth story, and Yum China for its extensive food network in China. These recommendations reflect a broader trend of institutional confidence in AI-driven and stable cash flow-generating companies as 2025 approaches.
